Cresemba 186 MG capsule UD 14S
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q28
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $63,642
Award facts
- Contract value 100% obligated
- $63,642.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $63,642.14 delivery order to AmerisourceBergen Drug Corp for the supply of Cresemba 186 mg capsules (unit dose, 14-count packages) under a firm fixed-price contract. This non-set-aside award, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, represents a child order against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cresemba (isavuconazole) is a critically important antifungal medication used in military and federal healthcare systems to treat serious fungal infections, making this procurement essential for military medical readiness and treatment capabilities.
This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen has demonstrated its capability to meet federal procurement requirements through competitive award processes and maintains an extensive portfolio supplying specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9Q28?
SPE2DR26F9Q28 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9Q28 worth?
The government has obligated $63,642 on SPE2DR26F9Q28.
Is contract SPE2DR26F9Q28 an order under another contract?
Yes. SPE2DR26F9Q28 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Q28 competed?
The extent of competition for SPE2DR26F9Q28 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award